Although the cells were selected only based on their Met expression levels and their response to HGF/SF treatment, the high-Met cell lines were assigned to the Claudin-low subtype by the Perou group while the low-Met cell lines are either of the luminal cancer subtype or normal cells (MCF10) [38]. This evidence concerns the gene HGF and cancer.